Patent Ductus Arteriosus (PDA) is a congenital cardiovascular anomaly characterized by the persistent patency of the ductus arteriosus, a vital fetal blood vessel that normally closes shortly after birth. This condition leads to abnormal blood flow between the pulmonary artery and the aorta, resulting in the mixing of oxygenated and deoxygenated blood. This can place undue stress on the heart, potentially causing complications such as heart failure if left untreated. Individuals with PDA may exhibit various symptoms, including but not limited to respiratory distress, inadequate weight gain, and an elevated susceptibility to respiratory infections. The clinical presentation can vary, and the severity of symptoms depends on the size of the patent ductus arteriosus. A prompt and accurate diagnosis is essential for effective management. Intervention options range from pharmacological approaches to surgical closure, with the choice depending on factors such as the patient's age, overall health, and the size of the ductus arteriosus. Medications that promote ductal closure or, in more severe cases, surgical procedures to physically seal the ductus arteriosus may be employed.